Manitoba Breakthrough Could Transform Breast Cancer Detection

Scientists in Winnipeg have solved a puzzle that could make breast cancer detection safer and more accessible for millions of women.

At the University of Manitoba, electrical and computer engineering professor Joe LoVetri and his team have developed the world's first imaging system that combines ultrasound with microwave technology. The breakthrough addresses a real need: better follow-up screening after mammograms without exposing patients to additional radiation.

"After a mammogram, to determine whether there truly is cancer in there," LoVetri explained. The dual-mode system would serve as a secondary scan, helping doctors confirm diagnoses with greater accuracy.

LoVetri's team has already tackled the major scientific challenges. Now they're partnering with Taumedis, a Winnipeg medical imaging company, to transform their lab prototypes into a product ready for clinical use.

"Our job is to transform the prototype into a product that is both comfortable and acceptable to the clinical community," said Henry Floreal, Taumedis co-founder and CEO. The company plans to handle everything from human studies through FDA approval and eventual commercialization.

The Ripple Effect

This innovation could reshape breast cancer care across North America. The technology produces no ionizing radiation, making it safer than repeated mammograms or CT scans. It also promises to be more comfortable for patients, removing one barrier that sometimes keeps women from follow-up appointments.

For Manitoba's healthcare system, the benefits extend beyond patient care. Floreal points out that wait times for diagnostic imaging can stretch for weeks or months. An additional screening tool could ease that bottleneck while keeping cutting-edge medical technology development in the province.

The first human study awaits regulatory and ethics approvals but could launch later this year. Those results will determine the path to market, including the timeline for FDA filing and commercial licensing.

Researchers can't predict exactly when the technology will reach hospitals and clinics. But they're committed to seeing it through, knowing the potential impact on women facing the uncertainty of a possible cancer diagnosis.

The work represents years of innovation coming together at exactly the right moment, when healthcare systems are actively seeking better diagnostic tools that put patient comfort and safety first.